• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Catalog Number UNK SGC03
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiogenic Shock (2262); Atrial Perforation (2511)
Event Date 07/02/2020
Event Type  Injury  
Manufacturer Narrative
Dates estimated.(udi#): in the absence of a reported part number, the udi number cannot be calculated.The device remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Article attached: iatrogenic atrial septal defect following the mitraclip procedure: a state-of-the-art review.
 
Event Description
This is filed to report after the mitraclip procedure, the atrial perforation had to be closed with an occulder.It was reported that this was a mitraclip procedure to treat mitral regurgitation (mr) with grade 4.One clip was implanted.After the procedure, bidirectional shunt with dominant left to right shunt and a small end-diastolic right to left shunt and cardiogenic shock occurred.An occluder device was placed at the end of the mitraclip procedure.Details are listed in the attached article, iatrogenic atrial septal defect following the mitraclip procedure: a state-of-the-art review.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record could not be performed as lot and part number was not provided.Based on the information available, a definitive cause for the reported patient effects could not be determined.However, patient effects of atrial perforation and cardiogenic shock are listed in the mitraclip instructions for use as known possible complications associated with mitraclip procedures.Additional therapy/ non-surgical treatment was a result of case-specific circumstances as an occluder device was placed at the end of the mitraclip procedure.Although a conclusive cause for the reported patient effects and the relationship to the device, if any, cannot be determined, there is no indication of a product issue with respect to manufacture, design or labeling.D1: brand name changed from unknown mitraclip to mitraclip® system steerable guide catheter d2.Product code changed from nkm to dra.D4.Catalog no.Changed from unk cds to unk sgc03.D6.Implant date removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10422383
MDR Text Key203449946
Report Number2024168-2020-06872
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 10/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SGC03
Was Device Available for Evaluation? No
Date Manufacturer Received10/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-